Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
The Native Antigen Company Ltd
The Native Antigen Company Ltd
Activities:
Ingredients
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
The Native Antigen Company strengthens senior team to support growing product portfolio
Appointments of Business Development Manager and Senior Product Manager follow move to state-of-the-art new facilities at Oxford Technology Park
Research & Development
Native Antigen Company expands range of norovirus-like particles
Norovirus is a small non-enveloped, positive-sense RNA virus belonging to the Caliciviridae family. It is a major cause of non-bacterial acute gastroenteritis outbreaks
Ingredients
The Native Antigen Company introduces veterinary reagents
The range includes pathogens such as coronaviruses, Borrelia, Rift Valley fever virus, African swine fever virus, Toxocara and heartworm
Manufacturing
The Native Antigen Company launches SARS-CoV-2 antibodies
The introduction of these antibodies extends The Native Antigen Company’s existing range and offers researchers a source of reagents for research
Ingredients
The Native Antigen Company introduces custom service for influenza antigens
The reagent supplier has announced the introduction of its custom contract service to rapidly develop antigen panels for influenza A and B viruses
Research & Development
BBI Solutions partners to distribute COVID-19 antigens in China
The Native Antigen Company has agreed distribution rights with BBI to provide coronavirus reagents in China
Ingredients
The Native Antigen Company introduces novel coronavirus antigen
UK company has developed rapid response manufacturing capabilities to produce reagents for emerging epidemic diseases
Subscribe now